直 Japanese PDF Font
  • 弁護士等
  • 業務内容
  • 論文等
  • オフィス
  • 事務所概要
  • 採用情報
Finnegan
  • 最新情報
  • Finneganについて
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • プロボノ活動
  • 事務所運営管理
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

James R. Barney

Fed. Circ. Makes Induced Infringement Easier to Prove

August 31, 2012

Law360

On Friday, August 31, the Federal Circuit ruled in favor of Finnegan client Akamai, in a 6-5 en banc decision that “a party can be held liable for induced infringement if it performs some steps of a patent and induces others to perform the remaining steps.”  Finnegan partner Kara F. Stoll stated, “the ruling eliminates the situation that existed under the previous ruling in which companies could avoid another’s patent rights by having an unrelated company perform one step of a patented process. Now there's an opportunity for patent owners to prove infringement in these circumstances. Ms. Stoll added, “Companies that develop this type of invention will have their patent properly protected.”  Finnegan represented Akamai in this matter.

Related Practices

グローバルな知的財産権利の執行、訴訟、および裁判

Related Industries

Electrical and Computer Technology

金融サービス・ビジネスシステム

Related Professionals

Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email

Related News

Award/Ranking

Forbes Names Finnegan Partner Erika Harmon Arner on its Inaugural 2026 America’s Top Women Lawyers List

June 5, 2026

Award/Ranking

Finnegan Earns Top Rankings in 2026 IAM Patent 1000 Guide; Nearly 60 Attorneys Ranked

May 28, 2026

Commentary

Quince Aims to Have ‘Dupe’ Evidence Shape Ugg Shoe Patent Trial

May 26, 2026

Award/Ranking

Finnegan Partner Antje Brambrink Shortlisted for Women in Business Law EMEA Award

May 13, 2026

Press Release

Finnegan Secures Decisive ITC Victory for Innoscience in Final Determination

May 11, 2026

Commentary

ITC Bars Import of Innoscience Chips Made Before Redesign

May 8, 2026

Commentary

How Litigation Funding Disclosure Could Affect ITC Cases

May 7 , 2026

Commentary

Justices to Side with Generic Drugmakers in Patent Spat, Attorneys Predict

May 5, 2026

Commentary

Supreme Court Takes Up Generic Drug Labeling Fight

April 29, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • プライバシー
  • 免責事項
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP